Filing Details

Accession Number:
0001209191-15-048430
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-01 17:39:13
Reporting Period:
2015-06-01
Filing Date:
2015-06-01
Accepted Time:
2015-06-01 17:39:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA Biological Products, (No Disgnostic Substances) (2836) 460920988
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612095 Christopher Haqq 701 Gateway Boulevard
Suite 200
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-01 1,350 $40.95 262,815 No 4 S Direct
Common Stock Disposition 2015-06-01 700 $41.68 262,115 No 4 S Direct
Common Stock Disposition 2015-06-01 450 $42.68 261,665 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect See footnote
Footnotes
  1. Transaction pursuant to Rule 10b5-1 Plan adopted March 11, 2015.
  2. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $40.54 to $41.53. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.55 to $42.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $42.58 to $43.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee.